Search Press releases Keywords From To 11 May 2023 UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer Read More 27 Apr 2023 UCB’s General Meeting of Shareholders 2023 Read More 27 Apr 2023 UCB Receives Positive CHMP Opinions for Bimekizumab for the Treatment of Adults with Psoriatic Arthritis and Axial Spondyloarthritis in the European Union Read More 20 Apr 2023 UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting Read More 13 Apr 2023 UCB’s Rozanolixizumab and Zilucoplan Phase 3 Generalized Myasthenia Gravis studies published in prestigious The Lancet Neurology Journal Read More 24 Mar 2023 Acquisition of own shares Read More Pagination First page Previous page Previous … Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Page 39 … Page 35 of 65 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
